Proteome Sciences plc (AIM:PRM)
London · Delayed Price · Currency is GBP · Price in GBX 2.134
+0.334 (18.56%)
Jul 27, 2026, 3:33 PM GMT
Proteome Sciences Financials Overview
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3.76 | 3.76 | 4.89 | 5.03 | 7.78 | 5.13 |
Revenue Growth | -17.03% | -23.14% | -2.80% | -35.37% | 51.69% | 7.91% |
Gross Profit Gross Profit Growth | -0.08 | -0.08 | 0.67 | 1.65 | 4.77 | 2.96 |
Operating Income Operating Income Growth | -2.67 | -2.67 | -2.35 | -1.62 | 1.73 | 0.41 |
Net Income Net Income Growth | -3.06 | -3.06 | -3.41 | -2.44 | 1.33 | 0.07 |
Earnings Per Share EPS Growth | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 |
EPS Growth | - | - | - | - | 2050.00% | -80.00% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United States United States Growth | 3.4 | 3.4 | 4.61 | 3.84 | 6.26 | 4.22 |
United Kingdom (UK) United Kingdom (UK) Growth | 0.11 | 0.11 | 0.18 | 0.31 | 0.33 | 0.19 |
European Union (EU) (Excl. United Kingdom) European Union (EU) (Excl. United Kingdom) Growth | 0.24 | 0.24 | 0.06 | 0.86 | 1.16 | 0.52 |
Other Other Growth | 0 | 0 | 0.03 | 0.02 | 0.03 | 0.2 |
Total Total Growth | 3.76 | 3.76 | 4.89 | 5.03 | 7.78 | 5.13 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 0.78 | 0.78 | 1.13 | 2.03 | 3.99 | 2.39 |
Total Debt Total Debt Growth | 15.77 | 15.77 | 14.52 | 13.48 | 11.92 | 11.69 |
Net Cash (Debt) Net Cash Growth | -14.99 | -14.99 | -13.39 | -11.45 | -7.92 | -9.3 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.05 | -0.05 | -0.04 | -0.04 | -0.03 | -0.03 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -0.05 | -0.05 | -0.83 | -0.48 | 2.14 | 0.79 |
Capital Expenditures CapEx Growth | -0.1 | -0.1 | -0.22 | -0.24 | -0.32 | -0.2 |
Free Cash Flow Free Cash Flow Growth | -0.14 | -0.14 | -1.05 | -0.72 | 1.82 | 0.59 |
Free Cash Flow Growth | - | - | - | - | 209.17% | -62.48% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | -2.16% | -2.16% | 13.71% | 32.76% | 61.27% | 57.71% |
Operating Margin | -70.98% | -70.98% | -48.15% | -32.24% | 22.21% | 8.03% |
Pretax Margin | -95.61% | -95.61% | -66.44% | -48.09% | 16.13% | 2.30% |
Profit Margin | -109.72% | -109.72% | -63.21% | -47.59% | 15.23% | 3.20% |
FCF Margin | -3.81% | -3.81% | -21.49% | -14.28% | 23.41% | 11.48% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 8.14 | 256.25 |
Forward PE | - | 86.11 | 86.11 | 86.11 | 86.11 | 86.11 |
P/FCF Ratio | - | - | - | - | 5.67 | 25.68 |
PS Ratio | 1.77 | 1.96 | 2.05 | 2.66 | 1.33 | 2.95 |